Fluorescence Guided Surgery in Breast Cancer
NCT02583568
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Bevacizumab-800CW
Sponsor
University Medical Center Groningen
Collaborators
[object Object]